• NewAmsterdam Pharma (NASDAQ:NAMS) Earns "Buy" Rating from HC Wainwright

    المصدر: Buzz FX / 14 يناير 2025 08:16:16   America/New_York


    NewAmsterdam Pharma (NASDAQ:NAMS) Earns "Buy" Rating from HC Wainwright Written by MarketBeat January 14, 2025 Share Link copied to clipboard. NewAmsterdam Pharma ( NASDAQ:NAMS - Get Free Report ) 's stock had its "buy" rating reaffirmed by
    Read more...
شارك على،